- £1.02bn
- £1.31bn
- €3.07bn
Full Year Trading Update and Notice of Results
Holding(s) in Company
Brief: Zevra Therapeutics Executes Distribution Agreement to Broaden Access to MIPLYFFA for the Treatment of Niemann-Pick Disease Type C (NPC)
Holding(s) in Company
Director/PDMR Shareholding
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Director/PDMR Shareholding
Holding(s) in Company
Holding(s) in Company
Brief: Uniphar To Deliver Double-Digit Adjusted EPS Growth For FY25
2025 Interim Results
Half Year Trading Update and Notice of Results
Holding(s) in Company
Holding(s) in Company
Director/PDMR Shareholding
AGM Results